Council conclusions on organ donation and transplantation were adopted last week by the Health Ministers of the 27 EU countries together with EU Commissioner for Health and Consumer Policy, Tonio Borg.
On 1st December 2012, the UEMS Advisory Council on CME will be held in Brussels. This Council aims at discussing the strategy of the UEMS-EACCME and gathers Members of UEMS Specialist Sections and European Boards and Members of National Accreditation Authorities which are partnering in the framework of the UEMS-EACCME. In the framework of this meeting, the new UEMS policy document on CME (UEMS 2012.30) will notably be largely discussed.
The Commission published today a report on patient safety which focuses on the state of implementation of a number of actions to increase patient safety agreed to by the EU's member states in 2009. Patient safety means that patients are not exposed to unnecessary harm or potential harm associated with healthcare, including the prevention and control of healthcare associated infections.
On 7th November 2012, The European Hospital and Healthcare Federation (HOPE) organised a round table addressing the issue of "Clostridium difficile" infection (CDI) and other healthcare-associated infections (HAIs). CDI is a leading Healthcare Associated Infection in Europe and is mainly caused by the use of antibiotics, which can clear the normal 'good' bacteria from the bowel and allow the overgrowth of C. difficile.
Summary of key decisions The Council of UEMS gathered on 18th and 19th October 2012 in Larnaca (Cyprus). On that occasion, the Members of UEMS discussed and agreed the following:
In the framework of the ECAB project (Evaluating Care across Borders), the London School of Hygiene and Tropical Medicine is conducting research on variations of practice in disease management across Europe. The ECAB Project is funded under the European Commission's 7th Research Framework Programme and the UEMS was invited to contribute both within the project's advisory board but also in providing its network in order to collect data.
The European Commission has launched a public consultation aiming at collecting views of stakeholders with regard to the use of medicinal products for children in Europe. Five years after it entered into force, the Commission aims to evaluate the strength and weaknesses of the legislative framework for paediatric medicinal products.
Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Next